PRAC meeting highlights 5-8 June 2023

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

The PRAC did not start or conclude any referral procedures during the June meeting. More information on all safety reviews currently under evaluation is provided in the 'Ongoing referrals' table.